Arrowstreet Capital, Limited Partnership Deciphera Pharmaceuticals, Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $121 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding DCPH
# of Institutions
6Shares Held
293KCall Options Held
500Put Options Held
0-
Jefferies Group LLC New York, NY175KShares$00.03% of portfolio
-
Virginia Retirement Systems Et Al Richmond, VA81KShares$00.01% of portfolio
-
Credit Suisse Ag Zurich, V836KShares$00.0% of portfolio
-
Cutler Group LP300Shares$00.0% of portfolio
-
Wipfli Financial Advisors Llc,204Shares$00.0% of portfolio
About Deciphera Pharmaceuticals, Inc.
- Ticker DCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,822,100
- Description
- Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...